Tratamiento crónico combinado con iloprost y sildenafil en un paciente con hipertensión pulmonar primaria

Iloprost, a prostacyclin analogue administered by inhalation, improves hemodynamic and functional class variables in patients with primary pulmonary hypertension. However, repetitive inhalations are required due to its short term effects. One potential approach to prolong and increase the effects of aerosolized iloprost might be to combine its use with phosphodiesterase inhibitors. We report a 36 years old female patient with primary pulmonary hypertension treated with this combination. After 18 months of therapy the patient had an improvement in functional class and in the 6 min walk distance despite persistence of high pulmonary pressures. Our case is in agreement with the reported beneficial effect of the association of sildenafil and iloprost. We postulate that functional improvement in primary pulmonary hypertension is not always related to a decrease in pulmonary artery pressure (Rev Méd Chile 2004; 132: 353-6).

Saved in:
Bibliographic Details
Main Authors: Isa P,Rodrigo, Castro G,Pablo, Martínez S,Alejandro
Format: Digital revista
Language:Spanish / Castilian
Published: Sociedad Médica de Santiago 2004
Online Access:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872004000300011
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0034-98872004000300011
record_format ojs
spelling oai:scielo:S0034-988720040003000112004-12-13Tratamiento crónico combinado con iloprost y sildenafil en un paciente con hipertensión pulmonar primariaIsa P,RodrigoCastro G,PabloMartínez S,Alejandro Iloprost Phosphodiesterase inhibitors Pulmonary heart disease Sildenafil Iloprost, a prostacyclin analogue administered by inhalation, improves hemodynamic and functional class variables in patients with primary pulmonary hypertension. However, repetitive inhalations are required due to its short term effects. One potential approach to prolong and increase the effects of aerosolized iloprost might be to combine its use with phosphodiesterase inhibitors. We report a 36 years old female patient with primary pulmonary hypertension treated with this combination. After 18 months of therapy the patient had an improvement in functional class and in the 6 min walk distance despite persistence of high pulmonary pressures. Our case is in agreement with the reported beneficial effect of the association of sildenafil and iloprost. We postulate that functional improvement in primary pulmonary hypertension is not always related to a decrease in pulmonary artery pressure (Rev Méd Chile 2004; 132: 353-6).info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.132 n.3 20042004-03-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872004000300011es10.4067/S0034-98872004000300011
institution SCIELO
collection OJS
country Chile
countrycode CL
component Revista
access En linea
databasecode rev-scielo-cl
tag revista
region America del Sur
libraryname SciELO
language Spanish / Castilian
format Digital
author Isa P,Rodrigo
Castro G,Pablo
Martínez S,Alejandro
spellingShingle Isa P,Rodrigo
Castro G,Pablo
Martínez S,Alejandro
Tratamiento crónico combinado con iloprost y sildenafil en un paciente con hipertensión pulmonar primaria
author_facet Isa P,Rodrigo
Castro G,Pablo
Martínez S,Alejandro
author_sort Isa P,Rodrigo
title Tratamiento crónico combinado con iloprost y sildenafil en un paciente con hipertensión pulmonar primaria
title_short Tratamiento crónico combinado con iloprost y sildenafil en un paciente con hipertensión pulmonar primaria
title_full Tratamiento crónico combinado con iloprost y sildenafil en un paciente con hipertensión pulmonar primaria
title_fullStr Tratamiento crónico combinado con iloprost y sildenafil en un paciente con hipertensión pulmonar primaria
title_full_unstemmed Tratamiento crónico combinado con iloprost y sildenafil en un paciente con hipertensión pulmonar primaria
title_sort tratamiento crónico combinado con iloprost y sildenafil en un paciente con hipertensión pulmonar primaria
description Iloprost, a prostacyclin analogue administered by inhalation, improves hemodynamic and functional class variables in patients with primary pulmonary hypertension. However, repetitive inhalations are required due to its short term effects. One potential approach to prolong and increase the effects of aerosolized iloprost might be to combine its use with phosphodiesterase inhibitors. We report a 36 years old female patient with primary pulmonary hypertension treated with this combination. After 18 months of therapy the patient had an improvement in functional class and in the 6 min walk distance despite persistence of high pulmonary pressures. Our case is in agreement with the reported beneficial effect of the association of sildenafil and iloprost. We postulate that functional improvement in primary pulmonary hypertension is not always related to a decrease in pulmonary artery pressure (Rev Méd Chile 2004; 132: 353-6).
publisher Sociedad Médica de Santiago
publishDate 2004
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872004000300011
work_keys_str_mv AT isaprodrigo tratamientocronicocombinadoconiloprostysildenafilenunpacienteconhipertensionpulmonarprimaria
AT castrogpablo tratamientocronicocombinadoconiloprostysildenafilenunpacienteconhipertensionpulmonarprimaria
AT martinezsalejandro tratamientocronicocombinadoconiloprostysildenafilenunpacienteconhipertensionpulmonarprimaria
_version_ 1755988128421642240